Delivery Order SPE2DB22D3010-SPE2DB25FP2DL

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,154.22 firm fixed-price contract is for the delivery of Itraconazole 10 mg/ml solution in 150 ml containers, with a period of performance through May 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
This is a $6,429.58 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Itraconazole 10 mg/ml solution 150ml, a medication used to treat fungal infections. The contract has an ultimate completion date of May 30, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 150 ml bottles of the medication Itraconazole 10 mg/ml solution, with a ceiling value of $8,080.61 and a performance period through July 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 100 mg itraconazole capsules, a medication used to treat fungal infections. The contract has a firm fixed price, a ceiling value of $1,440.65, and a performance period extending through May 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ITRACONAZOLE 10 MG/ML SOLUTION 150ML, with a ceiling value of $5,336.88 and a completion date of June 4, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a major defense supply chain management agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The contract has a ceiling value of $4,955.04 and a completion date of May 30, 2025. It is for the delivery of various pharmaceutical and medical products to support federal agencies, particularly the military and veteran healthcare systems. Amerisourcebergen Drug Corp holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $70,093.32 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, awarded on August 5, 2024, has an ultimate completion date of August 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $20,661.44 and an ultimate completion date of April 8, 2025. The contract provides a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of medical products and supplies. The contract, valued at $597,775.17, has an ultimate completion date of October 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to provide a wide range of medical supplies and prescription drugs. The $1,099.20 firm fixed price contract has an ultimate completion date of August 28, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that the DLA Troop Support...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB25FP2DL
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Itraconazole 10 mg/ml solution. The contract has a ceiling value of $2,941.92 and an ultimate completion date of April 10, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/9/25, 9:49 AM